• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期恶性胸膜间皮瘤的转化手术。

Conversion surgery for locally advanced malignant pleural mesothelioma.

机构信息

Division of Thoracic Surgery, Shizuoka Cancer Center, Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

出版信息

Gen Thorac Cardiovasc Surg. 2020 Dec;68(12):1547-1550. doi: 10.1007/s11748-020-01329-y. Epub 2020 Mar 12.

DOI:10.1007/s11748-020-01329-y
PMID:32166578
Abstract

Two women in their sixties were diagnosed with inoperable locally advanced epithelioid malignant pleural mesothelioma, c-stage IIIB. Post-chemotherapy, the tumors down-staged to yc-stage IA, and pleurectomy/decortication were performed. The pathological diagnoses were p-stages II and IA. One patient had tumor recurrence 6 months after surgery; she is currently undergoing fourth-line chemotherapy and is alive 30 months postoperatively. The second patient had tumor recurrence 4 months after surgery and died 2 months later. Conversion surgery for advanced malignant mesothelioma does not improve progression-free survival but might have a chance to extend overall survival in selected patients without deteriorating performance status.

摘要

两位六十多岁的女性被诊断为不能手术的局部晚期上皮样恶性胸膜间皮瘤,c 期 IIIB 期。化疗后,肿瘤降期为 yc 期 IA 期,并进行了胸膜切除术/剥脱术。病理诊断为 p 期 II 期和 IA 期。一位患者在手术后 6 个月肿瘤复发;她目前正在接受四线化疗,手术后 30 个月仍存活。第二位患者在手术后 4 个月肿瘤复发,2 个月后死亡。对于晚期恶性间皮瘤,转换手术并不能改善无进展生存期,但在不恶化功能状态的情况下,可能有机会延长某些患者的总生存期。

相似文献

1
Conversion surgery for locally advanced malignant pleural mesothelioma.局部晚期恶性胸膜间皮瘤的转化手术。
Gen Thorac Cardiovasc Surg. 2020 Dec;68(12):1547-1550. doi: 10.1007/s11748-020-01329-y. Epub 2020 Mar 12.
2
Peritoneal Dissemination in Patients with Recurrence After Post-pleurectomy/decortication for Pleural Mesothelioma.胸膜间皮瘤行胸膜切除/剥脱术后复发患者的腹膜播散。
Ann Surg Oncol. 2024 Nov;31(12):7767-7774. doi: 10.1245/s10434-024-15984-5. Epub 2024 Aug 10.
3
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.广泛胸膜切除术和化疗与单纯化疗治疗胸膜间皮瘤(MARS 2):一项 3 期随机对照试验。
Lancet Respir Med. 2024 Jun;12(6):457-466. doi: 10.1016/S2213-2600(24)00119-X. Epub 2024 May 10.
4
Non-incisional pleurectomy-decortication for malignant pleural mesothelioma.非切开式胸膜切除术-纤维板剥脱术治疗恶性胸膜间皮瘤
Surg Today. 2018 Jun;48(6):656-658. doi: 10.1007/s00595-018-1624-0. Epub 2018 Feb 28.
5
Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.老年恶性胸膜间皮瘤的扩大胸膜切除术剥脱术:需要一种包容但有选择性的方法。
Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):696-702. doi: 10.1093/icvts/ivx221.
6
Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma.扩大性胸膜切除术及纤维板剥脱术治疗恶性胸膜间皮瘤
Thorac Surg Clin. 2020 Nov;30(4):451-460. doi: 10.1016/j.thorsurg.2020.07.002. Epub 2020 Sep 12.
7
Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma.恶性胸膜间皮瘤行胸膜切除术/剥脱术后复发的临床结果。
Ann Thorac Surg. 2020 May;109(5):1537-1543. doi: 10.1016/j.athoracsur.2019.11.048. Epub 2020 Jan 18.
8
Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.综合治疗:恶性胸膜间皮瘤的有效多模态方法。
Thorac Surg Clin. 2020 Nov;30(4):481-487. doi: 10.1016/j.thorsurg.2020.08.002.
9
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.胸膜间皮瘤治疗中胸膜剥脱术/去皮质术或活检后进行高剂量照射。
Cancer Radiother. 2017 Dec;21(8):766-773. doi: 10.1016/j.canrad.2017.05.007. Epub 2017 Nov 11.
10
Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.扩大胸膜剥脱术治疗恶性胸膜间皮瘤
Multimed Man Cardiothorac Surg. 2019 Nov 5;2019. doi: 10.1510/mmcts.2019.023.